Ignite Creation Date:
2024-05-06 @ 12:12 PM
Last Modification Date:
2024-10-26 @ 12:56 PM
Study NCT ID:
NCT03709121
Status:
COMPLETED
Last Update Posted:
2020-05-13
First Post:
2018-10-03
Brief Title:
A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber
Sponsor:
Aldeyra Therapeutics Inc
Organization:
Aldeyra Therapeutics Inc
Study Overview
Official Title:
An Exploratory Clinical Trial Evaluating Reproxalap Ophthalmic Solutions 025 and 05 in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber EEC
Status:
COMPLETED
Status Verified Date:
2018-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
An Exploratory Clinical Trial Evaluating Reproxalap Ophthalmic Solutions 025 and 05 in Subjects with Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber EEC
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None